Nationwide launch for pioneering fertility study
The NIHR-funded trial will assess whether removing small fibroids and endometrial polyps improves fertility and live births
Read More
Tag: fibroids
US delay for AbbVie/Neurocrine’s uterine pain drug
The US Food and Drug Administration has extended its review of AbbVie and Neurocrine’s experimental uterine pain drug elagolix by three months.
Read More
NICE backs non-surgical option for fibroids
Women with uterine fibroids stand to gain routine access to a non-surgical treatment on the National Health Service for the first time, after cost regulators endorsed Gedeon Richter’s once-daily pill Esmya as an option.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
